Wereport cases of serious arrhythmias associated with apical hypertrophic cardiomyopathy (AHCM).Thirty-one patients were referred to our institute to undergo further assessment of their AHCM from 1988 to 1999. Three patients with nonsustained ventricular tachycardia demonstrated an 123I-MIBG regional reduction in the tracer uptake. In two patients with ventricular fibrillation (VF), the findings from 123I-MIBG imaging revealed regional sympathetic denervation in the inferior and lateral regions. Electrophysiologic study demonstrated reproducible induction of VF in aborted sudden death and presyncopal patients, resulting in the need for an implantable defibrillator device and amiodarone in each patient. Patients with refractory atrial fibrillation with a rapid ventricular response suffered from serious congestive heart failure. A prudent assessment and strategy in patients with this disease would be indispensable in avoiding a disastrous outcome. (Internal Medicine 40: 396-402, 2001) 
Introduction
A form of hypertrophic cardiomyopathy (HCM) which is localized to the left ventricular apex was first described in Japan in 1976 (1) . This syndrome identified a morphologic variant of the disease in which wall thickening is confined to the most apical portion of the left ventricle and is associated with a striking electrocardiographic pattern of "giant" negative T waves (GNT) and a "spade shape" deformity of the left ventricle, as detected by contrast angiography (2) . Several reports from outside of Japan have reported that apical hypertrophic cardiomyopathy (AHCM) is not a disease confined to the Japanese people (3) (4) (5) . The prognosis of this syndrome has been regarded as being relatively good, and serious ventricular arrhythmias may be rare in these cases (6) . However, we had several cases in which serious ventricular arrhythmias occurred requiring intensive treatment.
Case Report
A 57-year-old man was referred to our institution for the assessment of aborted sudden death when he collapsed while playing tennis, and this was witnessed by neighbors (patient 28 in Table 1 ). One other patient, a 57-year-old male, suffered from recurrent presyncope, and Holter ambulatory monitoring examination revealed frequent episodes of nonsustained monomorphic ventricular tachycardia (VT) (patient 31 in Table 1 ). These two patients had a GNTon the 12-lead ECG, and left ventricular hypertrophy confined to the apex which was diagnosed by two-dimensional echocardiography. After informed consent was obtained, electrophysiological study was performed in these two patients in a fasting state. Details of the stimulation protocol and recording technique were as previously described (7) . Briefly, programmed ventricular stimulation was performed from the right ventricular apex and outflow tract with up to three premature extrastimuli. In patient 28, a survivor from aborted sudden death, two ventricular premature stimuli (S l-S2=230 msec, S2-S3=220 msec) at a basic cycle length of 600 msec provoked VF repeatedly without intravenous isoproterenol, and required D-C cardioversion to restore sinus rhythm. This patient received an ICDwithout concomitant antiarrhythmic agents.
In patient 3 1, with recurrent presyncopal attacks, two premature ventricular stimuli (Sl-S2=220 msec, S2-S3=210 msec) at a basic cycle length of 600 msec also repeatedly induced sustained polymorphic VTwhich then degenerated into VFand necessitated D-Ccardioversion to restore sinus rhythm. This patient had been taking 10 mg/day of bisoprolol and underwent a repeat electrophysiologic study resulting in the failure to suppress the sustained polymorphic VT. The patient then began taking 200 mg/day of amiodarone and repeated the electrophysiologic study which demonstrated complete supression of any kind of dysrhythmia. Neither endomyocardial biopsy nor signal averaged electrocardiography were performed in these patients. In patient 23 (72-year-old male) with a GNTassociated with a hypertrophic left ventricle and whoseclinical symptomwas a near syncopal attack, two premature ventricular stimuli were delivered with three different basic cycle lengths (600, 500 and 400 msec) from two different sites in the right ventricle (apex and outflow tract) resulting in the provocation of nonsustaiend polymorphic VTwhich had no specific meaning. MIBGmyocardial scintigraphy was performed in the steady state after fasting in patients receiving therapy but without medication on the day of the test. Nopatients had diabetes mellitus or renal or liver disease, which could affect 123I-MIBG uptake or metabolism. After a 30-minute rest period, 1 1 IMBq of iodine-123MIBG (Daiichi Radioisotope Laboratory, Tokyo) was intravenously injected and anterior planar images were obtained 30 minutes (initial image) and 3 hours (delayed image) after the injection with a low-energy collimator attached to a rotation-type gammacamera (YokokawaStarcam 4000iXR/ T, Tokyo). Twenty minutes (early phase) and 4 hours (late phase) after the injection, a 3-minute planar scan in the anterior view was obtained, after which a 20-minute SPECTimage was obtained. SPECTwas also performed about 3 hours after the tracer administration with data collections of 30-40 seconds each, starting in the 45°right anterior oblique projection and finishing in the 45°left posterior oblique projection, after which a series of transaxial images was reconstructed using filtered backprojection. To determine the control data, we performed MIBGmyocardial scintigraphy in five AHCMpatients in whom no ventricular arrhythmias were documentedby ambulatory ECGmonitoring examination with the same protocol. In two patients (No. 28. broad lateral to inferior region of the left ventricle (Fig. 1) . Patient 3 1 treated with amiodarone has been free from any presyncopal episodes. Patient 28 received an ICD and no further events were noted for 29 months after the device implantation. Both abnormal endocardial electrograms such as fractionated electrograms and late potentials were absent in all these patients.
Another two patients (No. 1 and 10 in Table 1 ) with almost comparable electrocardiographic and echocardiographic findings suffered from congestive heart failure due to sustained atrial fibrillation with a very rapid ventricular response necessitating hospitalization. These two patients received ACEinhibitors and digitalis combined with antiarrhythmic agents (aprindine: 60 mg/day, and procainamide: 1 ,500 mg/day), however, they still required rehospitalization to treat the recurrence of congestive heart failure.
All patients were alive at a mean follow-up of 54 months (range 2 1-1 22 months). Cardiac catheterization was performed to confirm the diagnosis ofAHCM in all these patients. Left ventriculography revealed a "spade-like" cavity configuration and increased apical wall thickness in the diastolic frame in all patients (Fig. 2) . The average ejection fraction of the left ventricle was 72.9+1 1. 1 %. No intraventricular gradient was present under the baseline conditions. Discussion
Over a 10-year period (1989 to 1999), 31 patients with AHCM were diagnosed and studied in our institution. The diagnostic criteria were based on two-dimensional echocardiographic demonstration of symmetric hypertrophy confined predominantly to the left ventricular apex, an apical thickness of >15 mmand a ratio of the maximal apical to posterobasal wall thickness >1.5 : 1 in the absence of cardiac or systemic disease that could itself explain this hypertrophy. Two-dimensional echocardiographic images were obtained in the standard transducer positions to define the distribution of the left ventricular hypertrophy (8, 9) . The pertinent clinical characteristics of all the patients are summarizedin Table 1 . Eighteen patients were male and thirteen female, and their mean (±SD) age was 67.2±17.4 years (range 29 to 84). In 24 patients, the major symptoms included atypical chest pain (n=15), palpitations (n=4), presyncope or syncope (n=3), dyspnea (n=l), and aborted sudden death (n=l). A giant negative T wave (GNT), which means an inverted T wavewhoseamplitude exceeds 1.0 mV,was present in all patients (Fig. 3) . Left ventricular hypertrophy (Romhilt and Estes score >5 (10)) was present in 27 patients.
Twenty-eight patients had ambulatory ECGmonitoring performed for one or more 24 hours periods. Recordings were independently reviewed for the presence of atrial and ventricular arrhythmias.
AHCM has previously been reported mainly in Asian patients, which demonstrated a striking ECGpattern of a GNT and an angiographic silhouette showingan enddiastolic deformation of the left ventricular cavity resembling a "spade". Although the identification of individuals with HCMat risk for sudden death and its effective prevention remain to be major therapeutic issues, the long-term prognosis of AHCM is considered to be good and no prudent care has been taken for this disease. In order to examine the actual prevalence ofAHCM, we surveyed the reports which have been published dealing with AHCM(3, ll-13). However, many of those cases did not have precisely the same morphologic entity as the patients described in the Japanese studies, therefore, they described a somewhatdifferent disease spectrum. Louie et al, also stated that the majority of those cases did not convincingly exhibit both a GNTand a spade shaped deformity of the left ventricle (14) , and therefore, many of those cases did not satisfy the diagnostic criteria of this disease. Although the abnormal hypertrophic process generally appears to becomemanifest in middle age (15) , Koga et al, demonstrated that young age (<20 years) was an important determinant of a poor prognosis in AHCM (16) . The time of the first episode of cardiac arrest occurred at the age of 56 in one of our patients. Therefore, external or internal stimulation such as arterial hypertension, chronic hypoxia or neurohumoralfactors mayaffect the clinical course of this disease. In the literature, one patient was reported to have had sustained VT. However, that case was associated with an apical aneurysm formation in the left ventricle (6) . Strictly speaking, we would normally not consider this patient to be an AHCM case. Therefore, our cases are definitely the first ones associated with a lethal ventricular arrhythmia.
A hypertrophied apex of the left ventricle could predispose the myocardiumto ischemia due to a limited coronary flow reserve. However, serious ventricular arrhythmias mayrarely occur. Although atrial arrhythmias may occur appearing to be related to atrial dilatation, the potential exists for ischemic arrhythmias in the absence of large vessel coronary artery disease as well as diastolic dysfunction (6) . Atrial fibrillation is the arrhythmia most commonlyassociated with disability or risk of adverse events for patients with HCM (13) . In the present report, two patients with atrial fibrillation suffered from serious congestive heart failure, implying that AHCMalso has a pathophysiology such as that of the commontype of HCM. Therefore, the sameattention should be given to these patients as that given to patients with the commonform of HCMin order to control atrial tachyarrhythmias which may bring about an adverse outcome in these AHCM patients. With the commontype of HCM, some cellular disarray is present in virtually all patients who die of HCM.The foci of the disorganized cells dispersed throughout the left ventricular wall might impair the transmission of normal electrophysiological impulses and predispose that region to a disordered pattern of depolarization and repolarization, thereby serving as an arrhythmogenic substrate ( 1 3). This type of pathophysiology might also play a role in AHCM cases. Of note, one patient (patient 28) with aborted sudden death had only a sporadic isolated premature ventricular contraction revealed by an ambulatory Holter monitoring examination, and had no substantial family history of sudden death. This indicates that the results obtained from Holter ECG, as well as the family history, can not be a reliable marker to predict the prognosis of this disease. Gill et al, demonstrated that selective denervation of the myocardiummay be an important mechanismin the genesis of VT using the 123I-MIBG scintigram (17) . In the present study, the 123I-MIBGscintigram obtained from two patients with lethal ventricular arrhythmias showeda reduced tracer uptake in the lateral to inferior region of the left ventricle significantly differing from the control group. In the five patients in the control group, there was a homogeneous distribution of the i23I-MIBGuptake in all patients, with only a slight decline toward the apex of the left ventricle as has been reported in the normal population by others (18, 19) . In five patients with nonsustained monomorphic VT, 123I-MIBG SPECT demonstrated a homogeneous tracer uptake in three of five patients. In the remaining two patients, there was a reduced tracer uptake located in the anteroinferior and inferoapical areas of the left ventricle. Therefore, it is likely that all patients with a reduced 123I-MIBG tracer uptake should undergo electrophysiologic study for risk stratification of their lethal ventricular arrhythmias, even though the total numberof the patients in this study group was too small to conclude as such. For HCMpatients in a high risk subgroup, amiodarone or implantable cardioverter-defibrillators represent the principal therapeutic options at present (20) . A discreet strategy to treat AHCM cases will be necessary to avoid catastrophic results comparable to those of HCMpatients, even though the prognosis ofAHCMis usually relatively good.
Conclusion
In general AHCM is a disease with a relatively good prognosis. However, sporadic cases have the risk of having a malignant clinical course associated with serious ventricular tachyarrhythmias or congestive heart failure. Therefore, we think that a prudent strategy for managing this disease should be taken to avoid a catastrophic result.
